Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
Clinical trial NCT01576406 · COMPLETED
Trial details
- NCT number
- NCT01576406
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-06-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.